Willow Biosciences Inc.
CANSF
$0.0038
$0.001140.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.78% | 25.91% | 29.51% | 1.84% | -7.12% |
| Total Depreciation and Amortization | 125.93% | -10.78% | -1.19% | -3.48% | -34.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -119.75% | -1.13% | 119.92% | -3.60% | 118.42% |
| Change in Net Operating Assets | 286.01% | -126.17% | 133.99% | -77.18% | 366.55% |
| Cash from Operations | 64.26% | -24.27% | 58.71% | -56.19% | 52.61% |
| Capital Expenditure | 100.00% | -- | -- | -- | -44.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 1,862.75% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 156.81% | -- | -- | -- | 165.55% |
| Cash from Investing | 146.43% | -- | -- | 2,175.00% | 142.31% |
| Total Debt Issued | -274.75% | 99.82% | -- | -- | 65.78% |
| Total Debt Repaid | -33.33% | 1.00% | -1.01% | -3.66% | 53.98% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 850.59% | -25,200.00% | -100.37% | 1,069.57% | 2,400.00% |
| Cash from Financing | -141.61% | 86.71% | 379.89% | -78.34% | 383.90% |
| Foreign Exchange rate Adjustments | 678.38% | -227.59% | -78.36% | 143.37% | -494.23% |
| Miscellaneous Cash Flow Adjustments | -- | 200.35% | -- | -- | 198.57% |
| Net Change in Cash | -403.31% | 118.23% | 39.92% | -188.18% | 81.12% |